Norah M. Qassadi

Norah M. Qassadi


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2026 in Viruses
Verified
Journal Article
Open access
PDF file
MJMohammad Abdu Jareebi
Mohammad Abdu Jareebi
RARadwan A. Abutaleb
Radwan A. Abutaleb
NQNorah M. Qassadi
Norah M. Qassadi
AAAtheer Akoor
Atheer Akoor
OMOsama Ahmed Mobarki
Osama Ahmed Mobarki
GJGhazi I. Al Jowf
Ghazi I. Al Jowf
Background/Objectives: SARS-CoV-2 infection and COVID-19 vaccination have both been linked to post-acute alopecia, yet prevalence, patterns, and correlates remain poorly defined. We aimed to determine the prevalence and patterns of alopecia after SARS-CoV-2 infection and COVID-19 vaccination, and to identify independent correlates among Saudi adults. Methods: A cross-sectional study of 1261 Saudi adults (≥18 years) was conducted nationwide between March and July 2025 using a structured, self-administered, bilingual (Arabic/English) online questionnaire distributed via social media. Eligible participants had received at least one COVID-19 vaccine dose. Data captured demographics, vaccination type and dose history, prior SARS-CoV-2 infection, self-reported alopecia subtype guided by plain-language definitions, comorbidities, and nutritional status. Hair loss and subtypes were entirely self-reported and not clinically or dermoscopically confirmed. Chi-square tests assessed univariate associations, and multivariable logistic regression identified independent predictors of any self-reported hair loss. Results: Mean age was 28.0 ± 9.6 years; 62.1% were female, 97.7% vaccinated (76.0% Pfizer-BioNTech first dose, 58.1% three doses), and 53.6% reported prior COVID-19 infection. Overall self-reported hair loss prevalence was 62.4%, with hair loss reported by 57.5% of vaccinated and 49.7% of COVID-positive participants. Self-reported telogen effluvium was the predominant pattern (56.3%), followed by androgenetic alopecia (39.3%) and alopecia areata (2.7%). Independent correlates were female sex (aOR 4.89; 95% CI 3.78–6.32), vitamin/mineral deficiency (aOR 2.31; 1.73–3.09), iron deficiency anemia (aOR 1.89; 1.29–2.78), prior SARS-CoV-2 infection (aOR 1.31; 1.02–1.68), and COVID-19 vaccination (aOR 7.45; 2.51–22.12). Conclusions: Self-reported hair loss was reported by nearly two-thirds of Saudi adults after COVID-19 vaccination or infection. Female sex and correctable nutritional deficiencies are the strongest modifiable correlates and warrant targeted screening and counseling.